Optimize dietary intake of vitamin D: An epigenetic perspective

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 6, 2012, Pages 567-579

  Hossein Nezhad, Arash ^a   Holick, Michael F ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

25 hydroxyvitamin D; bone; dietary intake; epigenetic; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL; CYTOCHROME; CYTOCHROME P 450 24A1; CYTOCHROME P 450 27B1; CYTOCHROME P 450 2R1; DRUG METABOLITE; ERGOCALCIFEROL; HISTONE; MICRORNA; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN;

BREAST FEEDING; BYPASS SURGERY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE PREDISPOSITION; DRUG HYDROXYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; ETHNICITY; GENE EXPRESSION; GENETIC VARIABILITY; GRANULOMATOSIS; GROUPS BY AGE AND SEX; HEALTH HAZARD; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HUMAN; LACTATION; MALABSORPTION; MATERNAL NUTRITION; NUTRITIONAL HEALTH; OBESITY; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PROTEIN PROCESSING; REVIEW; RICKETS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SKIN PIGMENTATION; SUN EXPOSURE; SUNLIGHT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INTOXICATION; VITAMIN D METABOLISM; WELLBEING;

ANIMALS; DIETARY SUPPLEMENTS; EPIGENOMICS; HUMANS; MODELS, ANIMAL; PREVALENCE; RISK FACTORS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84868227810     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283594978     Document Type: Review

References (89)

1. & Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin North Am 2012; 38:141-160.
2. Smit E, Crespo CJ, Michael Y, et al. The effect of vitamin D and frailty on mortality among non institutionalized US older adults. Eur J Clin Nutr 2012 [Epub ahead of print].
3. Holick MF. Nutrition: D-iabetes and D-eath D-efying vitamin D. Nat Rev Endocrinol 2012; 8:388-390.
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
5. Brannon PB, Picciano MF. Vitamin D in pregnancy and lactation in humans. Annu Rev Nutr 2011; 31:89-115.
6. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-1930.
7. Nair R, Maseeh A. Vitamin D: the 'sunshine' vitamin. J Pharmacol Pharmacother 2012; 3:118-126.
8. Holick MF. The D-lightful vitamin D for child health. J Parenter Enteral Nutr 2012; 36 (1 Suppl):9S-19S.
9. Novakovic B, Galati JC, Chen A, et al. Maternal vitamin D predominates over genetic factors in determining neonatal circulating vitamin D concentrations. Am J Clin Nutr 2012; 96:188-195.
10. Kaludjerovic J, Vieth R. Relationship between vitamin D during perinatal development and health. J Midwifery Women's Health 2010; 55:550-560.
11. Shin JS, Choi MY, Longtine MS, Nelson DM. Vitamin D effects on pregnancy and the placenta. Placenta 2010; 31:1027-1034.
12. Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys 2012; 523:95-102.
13. Finer S, Khan KS, Hitman GA, et al. Inadequate vitamin D status in pregnancy: evidence for supplementation. Acta Obstet Gynecol Scand 2012; 91:159-163.
14. Feldt-Rasmussen U, Mathiesen ER. Endocrine disorders in pregnancy: physiological and hormonal aspects of pregnancy. Best Pract Res Clin Endocrinol Metab 2011; 25:875-884.
15. Liu NQ, Hewison M. Vitamin D, the placenta and pregnancy. Arch Biochem Biophys 2012; 523:37-47.
16. Tague SE, Smith PG. Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones. J Chem Neuroanat 2011; 41:1-12.
17. Vercruyssen J, Jacquemyn Y, Ajaji M. Effect of sun exposure and 25-hydroxyvitamin D status among pregnant women in Antwerp. Belgium Int J Gynaecol Obstet 2012; 116:76-77.
18. Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 2012; 523:9-18.
19. Papapetrou PD. The interrelationship of serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in pregnancy at term: a meta-analysis. Hormones (Athens) 2010; 9:136-144.
20. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58.
21. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012; 97:1146-1152.
22. Greene-Finestone LS, Berger C, de Groh M, et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 2011; 22:1389-1399.
23. Gonzá lez-Gross M, Valtueñ a J, Breidenassel C, et al. Vitamin D status among adolescents in Europe: the Healthy Lifestyle in Europe by Nutrition in Adolescence study. Br J Nutr 2012; 107:755-764.
24. Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr 2012; 142:498-507.
25. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 2011; 25:671-680.
26. Fields J, Trivedi NJ, Horton E, Mechanick JI. Vitamin D in the Persian Gulf: integrative physiology and socioeconomic factors. Curr Osteoporos Rep 2011; 9:243-250.
27. Daly RM, Gagnon C, Lu ZX, et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) 2012; 77:26-35.
28. Holick MF, Binkley NC, Bischoff-Ferrari HA. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012; 97:1153-1158.
29. Sacheck J, Goodman E, Chui K, et al. Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J Pediatr 2011; 159:945-950.
30. Shivane VK, Sarathi V, Bandgar T, et al. High prevalence of hypovitaminosis D in young healthy adults from the western part of India. Postgrad Med J 2011; 87:514-518.
31. Zhu Z, Zhan J, Shao J, et al. High prevalence of vitamin D deficiency among children aged 1 month to 16 years in Hangzhou, China. BMC Public Health 2012; 12:126.
32. Burris HH, Rifas-Shiman SL, Kleinman K, et al. Vitamin D deficiency in pregnancy and gestational diabetes mellitus. Am J Obstet Gynecol 2012 [Epub ahead of print].
33. Ginde AA, Sullivan AF, Mansbach JM, Camargo CA Jr. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol 2010; 202:436.
34. Johnson DD, Wagner CL, Hulsey TC, et al. Vitamin D deficiency and insufficiency is common during pregnancy. Am J Perinatol 2011; 28:7-12.
35. Baker AM, Haeri S, Camargo CA Jr, et al. A nested case-control study of firsttrimester maternal vitamin D status and risk for spontaneous preterm birth. Am J Perinatol 2011; 28:667-672.
36. Li W, Green TJ, Innis SM, et al. Suboptimal vitamin D levels in pregnant women despite supplement use. Can J Public Health 2011; 102:308-312.
37. Wei SQ, Audibert F, Hidiroglou N, et al. Longitudinal vitamin D status in pregnancy and the risk of preeclampsia. BJOG 2012; 119:832-839.
38. Ringrose JS, PausJenssen AM, Wilson M, et al. Vitamin D and hypertension in pregnancy. Clin Invest Med 2011; 34:E147-E154.
39. Makgoba M, Nelson SM, Savvidou M, et al. First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus. Diabetes Care 2011; 34:1091-1093.
40. Mahon P, Harvey N, Crozier S, et al. Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res 2010; 25:14-19.
41. Perez-Ferre N, Torrejon MJ, Fuentes M, et al. Association of low serum 25-Hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes. Endocr Pract 2012; 1:1-18.
42. Fernández-Alonso AM, Dionis-Sánchez EC, Chedraui P, et al. First-trimester maternal serum 25-hydroxyvitamin D status and pregnancy outcome. Int J Gynaecol Obstet 2012; 116:6-9.
43. Milman N, Hvas AM, Bergholt T. Vitamin D status during normal pregnancy and postpartum. A longitudinal study in 141 Danish women. J Perinat Med 2011; 40:57-61.
44. Saaf M, Fernell E, Kristiansson F, et al. Severe vitamin D deficiency in pregnant women of Somali origin living in Sweden. Acta Paediatr 2011; 100:612-614.
45. Viljakainen HT, Saarnio E, Hytinantti T, et al. Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab 2010; 95:1749-1757.
46. Miettinen ME, Reinert L, Kinnunen L, et al. Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia 2012; 55:1291-1294.
47. Perampalam S, Ganda K, Chow KA, et al. Vitamin D status and its predictive factors in pregnancy in 2 Australian populations. Aust N Z J Obstet Gynaecol 2011; 51:353-359.
48. Teale GR, Cunningham CE. Vitamin D deficiency is common among pregnant women in rural Victoria. Aust N Z J Obstet Gynaecol 2010; 50:259-261.
49. Shibata M, Suzuki A, Sekiya T, et al. High prevalence of hypovitaminosis D in pregnant Japanese women with threatened premature delivery. J Bone Miner Metab 2011; 29:615-620.
50. Tao M, Shao H, Gu J, Zhen Z. Vitamin D status of pregnant women in Shanghai, China. J Matern Fetal Neonatal Med 2012; 25:237-239.
51. Jing Wang, Fan Yang, Meng Mao, et al. High prevalence of vitamin D and calcium deficiency among pregnant women and their newborns in Chengdu, China. World J Pediatr 2010; 6:265-267.
52. Ustuner I, Keskin HL, Tas EE, et al. Maternal serum 25(OH)D levels in the third trimester of pregnancy during the winter season. J Matern Fetal Neonatal Med 2011; 24:1421-1426.
53. Halicioglu O, Aksit S, Koc F, et al. Vitamin D deficiency in pregnant women and their neonates in spring time in western Turkey. Paediatr Perinat Epidemiol 2012; 26:53-60.
54. Agarwal R, Virmani D, Jaipal ML, et al. Vitamin D status of low birth weight infants in Delhi: a comparative study. J Trop Pediatr 2012 [Epub ahead of print].
55. Hossain N, Khanani R, Hussain-Kanani F, et al. High prevalence of vitamin D deficiency in Pakistani mothers and their newborns. Int J Gynaecol Obstet 2011; 112:229-233.
56. Maghbooli Z, Hossein-Nezhad A, Karimi F, et al. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008; 24:27-32.
57. Narchi H, Kochiyil J, Zayed R, et al. Longitudinal study of vitamin D status in the 1st 6 months of life. Ann Trop Paediatr 2011; 31:225-230.
58. Al Kalbani M, Elshafie O, Rawahi M, et al. Vitamin D status in pregnant Omanis: a disturbingly high proportion of patients with low vitamin D stores. Sultan Qaboos Univ Med J 2011; 11:52-55.
59. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121:297-300.
60. Godar DE, Pope SJ, Grant WB, Holick MF. Solar UV doses of adult Americans and vitamin D(3) production. Dermatoendocrinol 2011; 3:243-250.
61. Autier P, Gandini S, Mullie P. A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab 2012; 97:2606-2613.
62. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010; 140:817-822.
63. Looker AC, Johnson CL, Lacher DA, et al. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011; 59:1-7.
64. Hollis BW, Wagner CL. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2012 [Epub ahead of print].
65. Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91:1255-1260.
66. Dong Y, Stallmann-Jorgensen IS, Pollock NK, et al. A 16-week randomized clinical trial of 2000 IU daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 2010; 95:4584-4591.
67. Runia TF, Hop WC, de Rijke YB, et al. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 2012; 79:261-266.
68. Løken-Amsrud KI, Holmøy T, Bakke SJ, et al. Vitamin D and disease activity in multiple sclerosis before and during interferon-b treatment. Neurology 2012; 79:267-273.
69. Disanto G, Sandve GK, Berlanga-Taylor AJ, et al. Vitamin D receptor binding, chromatin states and association with multiple sclerosis. Hum Mol Genet 2012; 21:3575-3586.
70. Walker CL, Ho SM. Developmental reprogramming of cancer susceptibility. Nat Rev Cancer 2012; 12:479-486.
71. Del Giudice M. Fetal programming by maternal stress: insights from a conflict perspective. Psychoneuroendocrinology 2012 [Epub ahead of print].
72. Stefanska B, Karlic H, Varga F, et al. Epigenetic mechanisms in anticancer actions of bioactive food components-the implications in cancer prevention. Br J Pharmacol 2012 [Epub ahead of print].
73. Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 2007; 113:1-13.
74. Barker D, Eriksson J, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31:1235-1239.
75. Karlic H, Varga F. Impact of vitamin D metabolism on clinical epigenetics. Clin Epigenetics 2011; 2:55-61.
76. Bell CG, Finer S, Lindgren CM, et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 2010; 5:e14040.
77. Burrell AM, Handel AE, Ramagopalan SV, et al. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC). Discov Med 2011; 11:187-196.
78. Novakovic B, Sibson M, Ng HK, et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009; 284:14838-14848.
79. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genomewide map of vitamin D3 receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352-1360.
80. Yu S, Cantorna MT. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol 2011; 186:1384-1390.
81. Fleming JL, Huang TH, Toland AE. The role of parental and grand parental epigenetic alterations in familial cancer risk. Cancer Res 2008; 68:9116-9121.
82. Curley JP, Mashoodh R. Parent-of-origin and trans-generational germline influences on behavioral development: the interacting roles of mothers, fathers, and grandparents. Dev Psychobiol 2010; 52:312-330.
83. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8:253-262.
84. Yu Zhou, Fengxiao Bu, Joan Lappe, et al. CYP2R1 is a potential candidate for predicting serum 25(OH)D variation as suggested by genetic and epigenetic studies. ASBMR 2010 AnnualMeeting S51, accessible at http://www.asbmr. org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid¼6ded1f50-9510- 4fbc-8aa1-92e36244330c.
85. Wjst M. Is vitamin D supplementation responsible for the allergy pandemic? Curr Opin Allergy Clin Immunol 2012; 12:257-262.
86. Tolppanen AM, Williams D, Henderson J, Lawlor DA. Serum 25-hydroxyvitamin D and ionised calcium in relation to lung function and allergen skin tests. Eur J Clin Nutr 2011; 65:493-500.
87. Martin R, Harvey NC, Crozier SR, et al. Placental calcium transporter (PMCA3) gene expression predicts intrauterine bone mineral accrual. Bone 2007; 40:1203-1208.
88. Pietras SM, Obayan BK, Cai MH, Holick MF. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 2009; 169:1806-1808.
89. Rajakumar K, de las Heras J, Lee S, et al. 25-hydroxyvitamin D concentrations and in vivo insulin sensitivity and b-cell function relative to insulin sensitivity in black and white youth. Diabetes Care 2012; 35:627-633.